Table 3.

Demographic data of included transitional zone prostate cancer patients.

Variables	Median (IQR) or n (%)
Patient based analysis (n = 70)
Age, yr	71.0 (64.0–74.5)
PSA, ng/dL	10.0 (6.9–22.3)
PSAD, ng/dL/cm3	0.30 (0.19–0.73)
Prostate volume (cm3)	32.8 (25.4–42.9)
TZ volume (cm3)	16.7 (11.2–20.4)
Lesion based analysis (n = 107)
Gleason score (GS)
6	17 (15.9%)
7(3 + 4)	41 (38.3%)
7(4 + 3)	25 (23.4%)
8 or more	24 (22.4%)

IQR = interquartile range, PSA = prostate-specific antigen, PSAD = PSA density, TZ = transitional zone.